This page shows the latest eIF4E inhibitor news and features for those working in and with pharma, biotech and healthcare.
Despite being highly oncogenic target which has garnered significant interest from the pharma industry, eIF4E has remained an evasive target for researchers. ... Importantly, we believe that this agreement validates Effector’s pursuit of eIF4E, which
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...